Streetbeat News

Revenues

RDZN

Roadzen (NASDAQ:RDZN) reported a significant improvement in its Q1 financial results. The company posted a loss of $(0.71) per share, an 89.45% improvement from the $(6.73) loss per share in the same period last year. Sales increased by 59.18% to $8.93 million from $5.61 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:31 pm

NPCE

NeuroPace has raised its FY24 revenue guidance from $73M-$77M to $76M-$78M, surpassing the estimated $75.899M. The company expects revenue growth to be driven by increasing sales of its RNS System and higher sales of DIXI Medical stereo EEG products.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:31 pm

THC

Tenet Healthcare (NYSE:THC) has significantly outperformed the market over the past 5 years, delivering an average annual return of 48.84%. A $1000 investment in THC 5 years ago would now be worth $7,511.80. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:30 pm

SCHW

Charles Schwab (NYSE:SCHW) has outperformed the market over the past 20 years with an average annual return of 9.63%, resulting in a $1000 investment growing to $6,489.10. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 13, 2024 | 8:30 pm

BTBD

BT Brands (NASDAQ:BTBD) reported a Q2 EPS of $(0.01), an improvement from $(0.04) YoY, and sales of $4.11M, up from $4.00M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:30 pm

GRTS

Gritstone Bio (NASDAQ:GRTS) reported Q2 earnings per share (EPS) of $(0.16), beating the analyst estimate of $(0.29) by 44.83%. However, the company missed sales estimates, reporting $921K against the expected $1.44M, a 35.82% shortfall. Compared to the same period last year, EPS improved by 48.39%, but sales decreased by 52.89%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:29 pm

DYAI

Dyadic International (NASDAQ:DYAI) reported Q2 2024 GAAP EPS of $(0.07), meeting analyst estimates, but missed sales expectations with $385.896K, a 53.90% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:29 pm

XOS

Xos has reaffirmed its FY24 guidance for deliveries of 400-600 units and revenue between $66.7 million and $100.4 million, with an estimated revenue of $80.98 million.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:29 pm

CC

The Chemours Company has opened a new Battery Innovation Center in Newark, Delaware, aimed at testing and scaling next-generation battery technologies for electric vehicles. This multi-million-dollar investment supports advancements in hybrid and electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:28 pm

EPSN

Epsilon Energy (NASDAQ:EPSN) reported a 100% increase in Q2 EPS to $0.04 and a 12.43% increase in sales to $7.31 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:26 pm